Optimal alpha-1 antitrypsin level cutoffs for genotype identification in patients with chronic liver disease
Background:. Controversy exists whether alpha-1 antitrypsin (A1AT) genotype testing should be performed as a first-line screening for A1AT heterozygous variants. Methods:. We calculated the median and interquartile range of A1AT level for each genotype in 4378 patients with chronic liver disease and...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Health/LWW
2023-02-01
|
| Series: | Hepatology Communications |
| Online Access: | http://journals.lww.com/10.1097/HC9.0000000000000023 |